Bicycle Therapeutics plc (BCYC)
NASDAQ·Healthcare·Biotechnology
$4.05
-1.34%
Mkt Cap $372.77M
Analyst Ratings
No recent rating data.
Price Target (13 analysts)
$11.00
Range $8.00 – $13.00
Implied Upside
+171.9%
Consensus $11.00 vs current $4.05
NASDAQ·Healthcare·Biotechnology
$4.05
-1.34%
Mkt Cap $372.77M
No recent rating data.
Price Target (13 analysts)
$11.00
Range $8.00 – $13.00
+171.9%
Consensus $11.00 vs current $4.05